Results (
Thai) 2:
[Copy]Copied!
3.10 Reporting on the guideline development process
The report should contain a description of the guideline development process, the dissemination and implementation and evaluation and revision strategies, and matters for future research.
The part of the report referring to guideline development should do the following:
• identify the organisation under whose aegis the guidelines were developed —who proposed, endorsed and funded the guidelines;
• define the purpose of the guidelines—for what audience(s) are the guidelines intended?
• indicate if different formats were required for different users;
• list the individuals and groups involved in developing the guidelines;
• document the processes and nature of the scientific evaluation of the evidence—for example, specify whether meta-analyses were used to analyse the literature or if consensus formed part of the guideline development process;
• provide a bibliography of materials used;
• contain a clear description of the scientific assumptions—whether relating to physiological assumptions, methods of actions of drugs or processes, expectations of deaths or morbidity following treatment, side-effects, and so on—that were incorporated in the evidence;
• record the public policy and cost questions considered and the method by which they were incorporated in the guidelines;
• identify the need for special training, equipment or facilities;
• describe the testing processes to which the guidelines were subjected;
• document the consultations undertaken; and
• record how consumer concerns were taken into account.
The part of the report dealing with dissemination, implementation, evaluation and revision should contain the following details:
• the target audience and other interested parties;
• methods of consultation and dissemination;
• specific plans for particular circumstances—such as remote or rural locations and links to institutional activities;
• the time frame for evaluation;
Being translated, please wait..